• Je něco špatně v tomto záznamu ?

Delivery of acute ischaemic stroke treatments in the European region in 2019 and 2020

D. Aguiar de Sousa, A. Wilkie, B. Norrving, C. Macey, C. Bassetti, C. Tiu, G. Roth, G. Lunde, H. Christensen, J. Fiehler, FR. Pezzella, M. Dichgans, MB. Roaldsen, P. Kelly, R. Mikulik, S. Sacco, V. Caso, U. Fischer, Steering Committee for the...

. 2023 ; 8 (3) : 618-628. [pub] 20230711

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23016365

INTRODUCTION: We assessed best available data on access and delivery of acute stroke unit (SU) care, intravenous thrombolysis (IVT) and endovascular treatment (EVT) in the European region in 2019 and 2020. PATIENTS AND METHODS: We compared national data per number of inhabitants and per 100 annual incident first-ever ischaemic strokes (AIIS) in 46 countries. Population estimates and ischaemic stroke incidence were based on United Nations data and the Global Burden of Disease Report 2019, respectively. RESULTS: The estimated mean number of acute SUs in 2019 was 3.68 (95% CI: 2.90-4.45) per one million inhabitants (MIH) with 7/44 countries having less than one SU per one MIH. The estimated mean annual number of IVTs was 21.03 (95% CI: 15.63-26.43) per 100,000 and 17.14% (95% CI: 12.98-21.30) of the AIIS in 2019, with highest country rates at 79.19 and 52.66%, respectively, and 15 countries delivering less than 10 IVT per 100,000. The estimated mean annual number of EVTs in 2019 was 7.87 (95% CI: 5.96-9.77) per 100,000 and 6.91% (95% CI: 5.15-8.67) of AIIS, with 11 countries delivering less than 1.5 EVT per 100,000. Rates of SUs, IVT and EVT were stable in 2020. There was an increase in mean rates of SUs, IVT and EVT compared to similar data from 2016. CONCLUSION: Although there was an increase in reperfusion treatment rates in many countries between 2016 and 2019, this was halted in 2020. There are persistent major inequalities in acute stroke treatment in the European region. Tailored strategies directed to the most vulnerable regions should be prioritised.

Center for Research and Education University Hospital of North Norway and Department of Clinical Medicine UiT The Arctic University of Norway Tromsø Norway

Department of Biotechnological and Applied Clinical Sciences University of L'Aquila L'Aquila Italy

Department of Clinical Neurosciences University of Medicine and Pharmacy 'Carol Davila' Bucharest and Department of Neurology University Hospital Bucharest Romania

Department of Clinical Sciences Section of Neurology Lund University Skåne University Hospital Lund Sweden

Department of Diagnostic and Interventional Neuroradiology University Medical Center Hamburg Eppendorf Hamburg Germany

Department of Neurology Copenhagen University Hospital Bispebjerg Copenhagen Denmark

Department of Neurology Inselspital Bern and Medical Faculty University of Bern Bern Switzerland

Department of Neurology University Hospital Basel University of Basel Basel Switzerland

Division of Cardiology Department of Medicine University of Washington Seattle WA USA

Institute for Stroke and Dementia Research University Hospital Ludwig Maximilian University Munich and German Center for Neurodegenerative Diseases Munich Germany

International Clinical Research Center and Department of Neurology St Anne's University Hospital in Brno and Faculty of Medicine at Masaryk University Brno Czech Republic

Irish Heart Foundation Dublin Ireland

Stroke Alliance for Europe Brussels Belgium

Stroke and Neurology Department Mater University Hospital and Stroke Clinical Trials Network Ireland University College Dublin Dublin Ireland

Stroke Center Lisbon Central University Hospital and Faculty of Medicine University of Lisbon Lisbon Portugal

Stroke Unit Department of Neuroscience San Camillo Forlanini Hospital Rome Italy

Stroke Unit Santa Maria della Misericordia Hospital University of Perugia Perugia Italy

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23016365
003      
CZ-PrNML
005      
20231026105956.0
007      
ta
008      
231013s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1177/23969873231186042 $2 doi
035    __
$a (PubMed)37431768
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Aguiar de Sousa, Diana $u Stroke Center, Lisbon Central University Hospital and Faculty of Medicine, University of Lisbon, Lisbon, Portugal $1 https://orcid.org/0000000267027924
245    10
$a Delivery of acute ischaemic stroke treatments in the European region in 2019 and 2020 / $c D. Aguiar de Sousa, A. Wilkie, B. Norrving, C. Macey, C. Bassetti, C. Tiu, G. Roth, G. Lunde, H. Christensen, J. Fiehler, FR. Pezzella, M. Dichgans, MB. Roaldsen, P. Kelly, R. Mikulik, S. Sacco, V. Caso, U. Fischer, Steering Committee for the Implementation of the Stroke Action Plan in Europe
520    9_
$a INTRODUCTION: We assessed best available data on access and delivery of acute stroke unit (SU) care, intravenous thrombolysis (IVT) and endovascular treatment (EVT) in the European region in 2019 and 2020. PATIENTS AND METHODS: We compared national data per number of inhabitants and per 100 annual incident first-ever ischaemic strokes (AIIS) in 46 countries. Population estimates and ischaemic stroke incidence were based on United Nations data and the Global Burden of Disease Report 2019, respectively. RESULTS: The estimated mean number of acute SUs in 2019 was 3.68 (95% CI: 2.90-4.45) per one million inhabitants (MIH) with 7/44 countries having less than one SU per one MIH. The estimated mean annual number of IVTs was 21.03 (95% CI: 15.63-26.43) per 100,000 and 17.14% (95% CI: 12.98-21.30) of the AIIS in 2019, with highest country rates at 79.19 and 52.66%, respectively, and 15 countries delivering less than 10 IVT per 100,000. The estimated mean annual number of EVTs in 2019 was 7.87 (95% CI: 5.96-9.77) per 100,000 and 6.91% (95% CI: 5.15-8.67) of AIIS, with 11 countries delivering less than 1.5 EVT per 100,000. Rates of SUs, IVT and EVT were stable in 2020. There was an increase in mean rates of SUs, IVT and EVT compared to similar data from 2016. CONCLUSION: Although there was an increase in reperfusion treatment rates in many countries between 2016 and 2019, this was halted in 2020. There are persistent major inequalities in acute stroke treatment in the European region. Tailored strategies directed to the most vulnerable regions should be prioritised.
650    _2
$a lidé $7 D006801
650    12
$a cévní mozková příhoda $x epidemiologie $7 D020521
650    12
$a ischemie mozku $x epidemiologie $7 D002545
650    _2
$a trombolytická terapie $7 D015912
650    _2
$a výsledek terapie $7 D016896
650    12
$a endovaskulární výkony $7 D057510
650    12
$a ischemická cévní mozková příhoda $x epidemiologie $7 D000083242
655    _2
$a časopisecké články $7 D016428
700    1_
$a Wilkie, Arlene $u Stroke Alliance for Europe, Brussels, Belgium
700    1_
$a Norrving, Bo $u Department of Clinical Sciences, Section of Neurology, Lund University, Skåne University Hospital, Lund, Sweden
700    1_
$a Macey, Chris $u Irish Heart Foundation, Dublin, Ireland
700    1_
$a Bassetti, Claudio $u Department of Neurology, Inselspital Bern and Medical Faculty, University of Bern, Bern, Switzerland
700    1_
$a Tiu, Cristina $u Department of Clinical Neurosciences, University of Medicine and Pharmacy 'Carol Davila' Bucharest, and Department of Neurology, University Hospital Bucharest, Romania $1 https://orcid.org/0000000185326218
700    1_
$a Roth, Greg $u Division of Cardiology, Department of Medicine, University of Washington, Seattle, WA, USA
700    1_
$a Lunde, Grethe $u Stroke Alliance for Europe, Brussels, Belgium
700    1_
$a Christensen, Hanne $u Department of Neurology, Copenhagen University Hospital, Bispebjerg, Copenhagen, Denmark $1 https://orcid.org/0000000274723194
700    1_
$a Fiehler, Jens $u Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
700    1_
$a Pezzella, Francesca Romana $u Stroke Unit, Department of Neuroscience, San Camillo Forlanini Hospital, Rome, Italy
700    1_
$a Dichgans, Martin $u Institute for Stroke and Dementia Research, University Hospital, Ludwig Maximilian University, Munich and German Center for Neurodegenerative Diseases (DZNE), Munich, Germany
700    1_
$a Roaldsen, Melinda B $u Center for Research and Education, University Hospital of North Norway and Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway $1 https://orcid.org/0000000348489063
700    1_
$a Kelly, Peter $u Stroke and Neurology Department, Mater University Hospital and Stroke Clinical Trials Network Ireland, University College Dublin, Dublin, Ireland $1 https://orcid.org/0000000347726565
700    1_
$a Mikulik, Robert $u International Clinical Research Center and Department of Neurology, St. Anne's University Hospital in Brno and Faculty of Medicine at Masaryk University, Brno, Czech Republic $1 https://orcid.org/0000000274585166
700    1_
$a Sacco, Simona $u Department of Biotechnological and Applied Clinical Sciences University of L'Aquila, L'Aquila, Italy $1 https://orcid.org/0000000306511939
700    1_
$a Caso, Valeria $u Stroke Unit, Santa Maria della Misericordia Hospital, University of Perugia, Perugia, Italy
700    1_
$a Fischer, Urs $u Department of Neurology, University Hospital Basel, University of Basel, Basel, Switzerland
710    2_
$a Steering Committee for the Implementation of the Stroke Action Plan in Europe
773    0_
$w MED00200144 $t European stroke journal $x 2396-9881 $g Roč. 8, č. 3 (2023), s. 618-628
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37431768 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231013 $b ABA008
991    __
$a 20231026105950 $b ABA008
999    __
$a ok $b bmc $g 2000090 $s 1202727
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 8 $c 3 $d 618-628 $e 20230711 $i 2396-9881 $m European stroke journal $n Eur Stroke J $x MED00200144
LZP    __
$a Pubmed-20231013

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...